Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that's 25 years of bringing you fearless, independent reporting. Since our very first broadcast in 1996, Democracy Now! has refused to take government or corporate funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. Please donate today in honor of our 25th anniversary and help us stay on air for another 25 years. We can't do our work without you. Right now, a generous donor will even DOUBLE your gift, which means it’ll go twice as far! This is a challenging time for us all, but if you're able to make a donation, please do so today. Thank you and remember, wearing a mask is an act of love.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


CDC to Issue Guidance for J&J Vaccine After Pause over Blood Clot Reports

HeadlineApr 19, 2021

A Centers for Disease Control and Prevention panel will meet Friday to issue recommendations on whether to resume use of Johnson & Johnson’s COVID vaccine. The U.S. temporarily halted use of the one-shot vaccine after at least six people reported an extremely rare blood clot disorder. On Friday, J&J scientists said there was “insufficient” evidence of a link between the clots and the vaccine. Dr. Anthony Fauci said over the weekend he expects the U.S. will resume its use.

Dr. Anthony Fauci: “My estimate is that we will continue to use it in some form. I doubt very seriously if they just cancel it. I don’t think that’s going to happen.”

South Africa’s health regulator has recommended resuming Johnson & Johnson vaccinations after also halting its rollout.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation